Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5324316 | 1.00 | NR1I2 (0.39) | NR1I2LMNAPGRFNTAFNTB | |
| SCHEMBL5324312 | 1.00 | NR1I2 (0.39) | NR1I2LMNAPGRFNTAFNTB | |
| SCHEMBL13871027 | 0.78 | NR1I2 (0.47) | NR1I2LMNAPGRFNTAFNTB | |
| SCHEMBL5178086 | 0.76 | KMT2A (0.53) | FNTAFNTBALDH1A1ALOX15 | |
| SCHEMBL5178090 | 0.76 | KMT2A (0.53) | FNTAFNTBALDH1A1ALOX15 | |
| SCHEMBL5178094 | 0.76 | KMT2A (0.53) | FNTAFNTBALDH1A1ALOX15 | |
| SCHEMBL13871026 | 0.75 | NR1I2 (0.53) | NR1I2LMNAPGRFNTAFNTB | |
| SCHEMBL13039636 | 0.69 | TRPA1 (0.40) | NR1I2LMNAPGRFNTAFNTB | |
| SCHEMBL13742848 | 0.68 | KMT2A (0.59) | NR1I2LMNAPGRFNTAFNTB | |
| SCHEMBL15948458 | 0.68 | ALDH1A1 (0.46) | LMNAPOLBALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090092642-A1 | Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure | BEIERSDORF AG (DE) | 2009-04-09 | — | — | US | disclosed |
| US-20090092642-A1 | Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure | BEIERSDORF AG (DE) | 2009-04-09 | — | — | US | disclosed |
| WO-2005102252-A9 | SKIN AND/OR HAIR PRODUCTS, CONTAINING COMPOUNDS WITH AN ISOPRENOID STRUCTURE | BEIERSDORF AG (DE) | 2007-01-11 | — | — | WO | disclosed |
| WO-2005102252-A9 | SKIN AND/OR HAIR PRODUCTS, CONTAINING COMPOUNDS WITH AN ISOPRENOID STRUCTURE | BEIERSDORF AG (DE) | 2007-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092642-A1 | Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure | SRD5A2, SRD5A1, CUTA | NR1I2 352/4885LMNA 1059/4885PGR 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.